The authors reported a small molecule construct, AzCDF, that allowed the therapeutic targeting of breast cancer stem cells and which was effective in normally refractory hypoxic tumor environments.
[Journal of the American Chemical Society]
7992332
{7992332:C7NZVSSV}
apa
50
1
165577
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
